| Outcome Measures: |
Primary: Change in 24-hour urine output, Change in urine output measured from 24-hour urine collection., Week 1|Change in 24-hour urine output, Change in urine output measured from 24-hour urine collection., Week 2|Change in 24-hour urine output, Change in urine output measured from 24-hour urine collection., Week 3|Change in 24-hour urine output, Change in urine output measured from 24-hour urine collection., Week 4|Change in 24-hour urine output, Change in urine output measured from 24-hour urine collection., Week 5|Change in residual renal function, Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection., Week 1|Change in residual renal function, Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection., Week 2|Change in residual renal function, Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection., Week 3|Change in residual renal function, Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection., Week 4|Change in residual renal function, Calculated based on weekly bloodwork (urea and creatinine levels) and 24-hour urine collection., Week 5 | Secondary: Interdialytic weight gain, Patient weight measured in kilograms, Week 1|Interdialytic weight gain, Patient weight measured in kilograms, Week 2|Interdialytic weight gain, Patient weight measured in kilograms, Week 3|Interdialytic weight gain, Patient weight measured in kilograms, Week 4|Interdialytic weight gain, Patient weight measured in kilograms, Week 5|Patient-reported outcomes - ESAS-r, Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire., Week 1|Patient-reported outcomes - ESAS-r, Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire., Week 2|Patient-reported outcomes - ESAS-r, Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire., Week 3|Patient-reported outcomes - ESAS-r, Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire., Week 4|Patient-reported outcomes - ESAS-r, Patient reported outcomes using the Edmonton Symptom Assessment System-revised (ESAS-r) questionnaire., Week 5|Patient-reported outcomes - Muscle cramps, Patient reported outcomes using a muscle cramps question., Week 1|Patient-reported outcomes - Muscle cramps, Patient reported outcomes using a muscle cramps question., Week 2|Patient-reported outcomes - Muscle cramps, Patient reported outcomes using a muscle cramps question., Week 3|Patient-reported outcomes - Muscle cramps, Patient reported outcomes using a muscle cramps question., Week 4|Patient-reported outcomes - Muscle cramps, Patient reported outcomes using a muscle cramps question., Week 5|Adverse effects, Adverse effects based on symptoms and weekly bloodwork., Week 1|Adverse effects, Adverse effects based on symptoms and weekly bloodwork., Week 2|Adverse effects, Adverse effects based on symptoms and weekly bloodwork., Week 3|Adverse effects, Adverse effects based on symptoms and weekly bloodwork., Week 4|Adverse effects, Adverse effects based on symptoms and weekly bloodwork., Week 5|Urine furosemide levels, Urine furosemide levels from weekly urine samples, Week 3|Urine furosemide levels, Urine furosemide levels from weekly urine samples, Week 4|Urine furosemide levels, Urine furosemide levels from weekly urine samples, Week 5
|
